Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study
Dermatologic Therapy, 06/22/2012
Clinical Article
De Simone C et al. – Corticosteroid withdrawal was possible in two patients, and enteric–coated mycophenolate sodium (EC–MPS) was very well tolerated. No serious adverse events were recorded. EC–MPS is a valid therapeutic opportunity as a steroid–sparing agent in pemphigus vulgaris (PV) patients.



